Matinas BioPharma Holdings, Inc.
MTNB
$0.5571
-$0.0429-7.15%
AMEX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -21.13M | -22.91M | -23.25M | -22.94M | -21.26M |
| Total Depreciation and Amortization | 965.00K | 959.00K | 952.00K | 941.00K | 927.00K |
| Total Amortization of Deferred Charges | 17.00K | 17.00K | -9.00K | 17.00K | 53.00K |
| Total Other Non-Cash Items | 4.21M | 4.45M | 4.76M | 5.04M | 5.11M |
| Change in Net Operating Assets | -1.01M | -390.00K | 588.00K | 1.67M | 176.00K |
| Cash from Operations | -16.95M | -17.87M | -16.96M | -15.28M | -15.00M |
| Capital Expenditure | 0.00 | -16.00K | -218.00K | -218.00K | -260.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 11.67M | 3.12M | 12.46M | 13.46M | 10.50M |
| Cash from Investing | 11.67M | 3.11M | 12.24M | 13.24M | 10.24M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -5.00K | -4.00K | -4.00K | -7.00K | -11.00K |
| Issuance of Common Stock | 9.24M | 9.24M | 54.00K | -- | 0.00 |
| Repurchase of Common Stock | -65.00K | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 9.17M | 9.24M | 50.00K | -7.00K | -11.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.89M | -5.53M | -4.67M | -2.04M | -4.77M |